Journal Article

Adipose Redistribution in Human Immunodeficiency Virus-Seropositive Patients: Association with CD4 Response

Rebecca Wurtz and Sarah Ceaser

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 31, issue 6, pages 1497-1498
Published in print December 2000 | ISSN: 1058-4838
Published online December 2000 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/317483
Adipose Redistribution in Human Immunodeficiency Virus-Seropositive Patients: Association with CD4 Response

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

We have noted that human immunodeficiency virus (HIV)-seropositive patients who develop adipose redistribution (AR) while receiving combination antiretroviral therapy (ART) also tend to have a better response to ART, as indicated by the relative change in CD4 percent compared to those who don't develop AR on therapy. Whether the possible benefits of the improved CD4 response outweigh the metabolic and cosmetic problems associated with lipodystrophy is not known.

Journal Article.  855 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.